BAX
Baxter International Inc
NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$23.37
-0.47% today
Updated 2026-09-25
Market cap
$11.85B
P/E ratio
—
P/S ratio
1.03x
EPS (TTM)
$-1.88
Dividend yield
0.88%
52W range
$16 – $30
Volume
6.7M
Baxter International Inc (BAX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$23.37
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$45.43
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1B | $10.1B | $10.4B | $10.6B | $11.2B | $11.2B | $11.1B | $11.0B | $10.9B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -0.75% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -9.27%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.